CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-11 | Bujarski Robert Joseph EVP & COO | Grant or award | +824 | 36,546 | ||
| 2023-02-11 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −434 | $86.50 | $38K | 36,112 |
| 2023-02-11 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units (Converted) | −2,749 | 0 | ||
| 2023-02-11 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units (Premium) | −824 | 0 | ||
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Grant or award | +7,309 | 529,238 | ||
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Shares withheld for taxes | −3,453 | $86.50 | $299K | 525,785 |
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Grant or award | +2,192 | 527,977 | ||
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Shares withheld for taxes | −1,087 | $86.50 | $94K | 526,890 |
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Exercise or conversion · Restricted Stock Units (Converted) | −7,309 | 0 | ||
| 2023-02-11 | BRYANT DOUGLAS C President & CEO | Exercise or conversion · Restricted Stock Units (Premium) | −2,192 | 0 | ||
| 2023-02-04 | Bujarski Robert Joseph EVP & COO | Grant or award | +3,623 | 36,259 | ||
| 2023-02-04 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −1,905 | $89.70 | $171K | 34,354 |
| 2023-02-04 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units | −3,623 | 0 | ||
| 2023-02-04 | BRYANT DOUGLAS C President & CEO | Grant or award | +18,720 | 531,211 | ||
| 2023-02-04 | BRYANT DOUGLAS C President & CEO | Shares withheld for taxes | −9,282 | $89.70 | $833K | 521,929 |
| 2023-02-04 | BRYANT DOUGLAS C President & CEO | Exercise or conversion · Restricted Stock Units | −18,720 | 0 | ||
| 2023-02-04 | Kroll Werner SVP, Research & Development | Grant or award | +3,925 | 26,190 | ||
| 2023-02-04 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,947 | $89.70 | $175K | 24,243 |
| 2023-02-04 | Kroll Werner SVP, Research & Development | Grant or award | +4,268 | 28,511 | ||
| 2023-02-04 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −2,117 | $89.70 | $190K | 26,394 |
Page 38 of 50 · 990 trades